Solid Biosciences (SLDB) Short-term Investments (2017 - 2024)
Solid Biosciences (SLDB) has disclosed Short-term Investments for 8 consecutive years, with $106.7 million as the latest value for Q3 2024.
- Quarterly Short-term Investments rose 13.72% to $106.7 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $106.7 million through Sep 2024, up 13.72% year-over-year, with the annual reading at $49.6 million for FY2023, 14.94% down from the prior year.
- Short-term Investments hit $106.7 million in Q3 2024 for Solid Biosciences, up from $94.4 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $106.7 million in Q3 2024 to a low of $90000.0 in Q2 2021.
- Historically, Short-term Investments has averaged $54.3 million across 5 years, with a median of $58.3 million in 2022.
- Biggest five-year swings in Short-term Investments: tumbled 99.02% in 2020 and later surged 103641.11% in 2022.
- Year by year, Short-term Investments stood at $400000.0 in 2020, then surged by 22060.75% to $88.6 million in 2021, then plummeted by 34.19% to $58.3 million in 2022, then fell by 14.94% to $49.6 million in 2023, then skyrocketed by 115.06% to $106.7 million in 2024.
- Business Quant data shows Short-term Investments for SLDB at $106.7 million in Q3 2024, $94.4 million in Q2 2024, and $88.5 million in Q1 2024.